Verquvo

Active Ingredient(s): Vericiguat
FDA Approved: * January 19, 2021
Pharm Company: * MERCK SHARP DOHME
Category: Heart (Cardiac)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Verquvo Overview

Vericiguat, sold under the brand name Verquvo, is a medication used to reduce the risk of cardiovascular death and heart failure.[1][2] It is taken by mouth.[1][2] Common side effects include low blood pressure and low red cell count (anemia).[2] Vericiguat is a soluble guanylate cyclase (sGC) stimulator.[1] It was approved for medical use in the United States in January 2021.[2]&am...

Read more Verquvo Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Vericiguat

Recent Verquvo Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Vericiguat
  • Tablet: 10mg, 2.5mg, 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Verquvo: (3 results)

Sorted by National Drug Code
  • 0006-5028 Verquvo 2.5 mg Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.
  • 0006-5029 Verquvo 5 mg Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.
  • 0006-5030 Verquvo 10 mg Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.

Other drugs which contain Vericiguat or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 April 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA